COMMUNIQUÉS West-GlobeNewswire

Stratice Healthcare achieves Certification through the Allscripts Developer Program for eOrdersPlus

02/04/2018 - 21:17

CARMEL, Ind., April 02, 2018 (GLOBE NEWSWIRE) -- Stratice Healthcare, creator of eOrdersPlus, a solution designed to streamline the ordering process for patients’ medical equipment and supplies needs, announced today [...]

UBM Americas’ Pharmaceutical Executive opens nominations for 2018 Emerging Pharma Leaders

02/04/2018 - 21:00

ISELIN, N.J., April 02, 2018 (GLOBE NEWSWIRE) -- UBM Life Sciences Group’s Pharmaceutical Executive today opened nominations for Emerging Pharma Leaders , an awards program that for 10 years has recognized and honored [...]

Molina Healthcare Announces First Quarter 2018 Earnings Release and Conference Call Dates

02/04/2018 - 21:00

LONG BEACH, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the first quarter ended March 31, 2018. Molina Healthcare will issue [...]

Oxford Performance Materials Announces Launch of OXPEKK®-LTS

02/04/2018 - 19:14

SOUTH WINDSOR, Conn., April 02, 2018 (GLOBE NEWSWIRE) -- Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM™), today announced the launch [...]

Arizona Legislature Approves Hyperbaric Oxygenation Treatment for Veterans with Traumatic Brain Injury, Reports the Association of American Physicians and Surgeons (AAPS)

02/04/2018 - 18:57

TUCSON, Ariz., April 02, 2018 (GLOBE NEWSWIRE) -- Veterans with traumatic brain injuries (TBI) and selected post-traumatic stress disorder (PTSD) conditions would be eligible to participate in hyperbaric oxygenation [...]

Zosano Pharma to Host Conference Call to Provide Operational Update

02/04/2018 - 18:56

FREMONT, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: ZSAN ), a clinical stage biopharmaceutical company focused on providing systemic administration of therapeutics to patients using [...]

Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference

02/04/2018 - 16:20

NORCROSS, Ga., April 02, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today announced that Peter G. Traber, M.D., the Company’ [...]

Progressive Care Enters Into Definitive Agreements to Purchase the Pharmacy in Palm Beach County

02/04/2018 - 15:12

MIAMI, April 02, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced today that it has entered into definitive agreements with the pharmacy in Palm Beach [...]

athenahealth Announces First Quarter 2018 Earnings Conference Call

02/04/2018 - 15:00

WATERTOWN, Mass., April 02, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that it will hold a [...]

Coherus BioSciences Management to Present at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco

02/04/2018 - 15:00

REDWOOD CITY, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ) today announced that senior management will be presenting at the H.C. Wainwright Annual Life Sciences Conference on [...]

Novavax to Present Clinical Data on RSV F and NanoFlu™ Vaccines at World Vaccine Congress

02/04/2018 - 15:00

Update on RSV F Vaccine Phase 3 Prepare ™ trial for infants via maternal immunization Results from Phase 1/2 trial of NanoFlu vaccine demonstrating improved immune responses compared to egg-based, high-dose flu vaccine [...]

Acology 10K Highlights Accomplishments, Looks Confidently Forward

02/04/2018 - 15:00

CORONA, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) released its 2017 10K report today, highlighted by steady growth and proportionately lowered operating expenses. In terms of the bottom [...]

Advantis Corp. Moves Forward With Pet Division

02/04/2018 - 15:00

NEWPORT BEACH, CA , April 02, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) announced it is moving forward with plans to establish a pet division that will create and market a proprietary line of CBD- [...]

SELLAS Life Sciences Announces Positive Interim Data from Phase 2b NeuVax™ (nelipepimut-S) Clinical Trial in Combination with Herceptin® in HER2 1+/2+ Breast Cancer Patients

02/04/2018 - 14:40

Clinically meaningful activity in favor of investigational nelipepimut-S (NeuVax) + Herceptin arm Clinically and statistically significant efficacy in triple negative breast cancer (TNBC) cohort; p=0.023 NEW YORK, April [...]

Marrone Bio Innovations to Present at The MicroCap Conference in New York on April 9th

02/04/2018 - 14:31

DAVIS, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII ), a leading provider of bio-based pest management and plant health products for the agriculture, [...]

Progenics Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference

02/04/2018 - 14:30

NEW YORK, April 02, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, [...]

First Choice Healthcare Solutions to Report Fourth Quarter and Full Year 2017 Results and Update on Strategic Partnership with Steward Health Care on April 3, 2018

02/04/2018 - 14:30

MELBOURNE, Fla., April 02, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB:FCHS) ("First Choice" or the "Company"), a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]

INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors

02/04/2018 - 14:30

PHOENIX, April 02, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]

MyoKardia Begins Dosing in Phase 2 MAVERICK-HCM Clinical Trial of Mavacamten in Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Patients

02/04/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]